IL-6 induces NF-κB activation in the intestinal epithelia

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3194-3201

  Wang, Lixin ^a   Walia, Baljit ^a   Evans, John ^a,c   Gewirtz, Andrew T ^b   Merlin, Didier ^a   Sitaraman, Shanthi V ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; ENTERITIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 0041832287     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3194     Document Type: Article

References (48)

1. Alonzi. T., E. Fattori, D. Lazzaro, P. Costa, L. Probert, G. Kollias, F. De Benedetti, V. Poli, and G. Ciliberto. 1998. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:461.
2. Tilg, H., C. A. Dinarello. and J. W. Mier. 1997. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18:428.
3. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6:583.
4. Yamamoto, M., K. Yoshizaki, T. Kishimoto, and H. Ito. 2000. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 164:4878.
5. Suzuki, A., T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, et al. 2001. CIS3/SOCS3/SS13 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471.
6. Reinisch, W., C. Gasche, W. Tillinger, J. Wyatt, C. Lichtenberger, M. Willheim, C. Dejaco, T. Waldhor, S. Bakos, H. Vogelsang, et al. 1999. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am. J. Gastroenterol. 94:2156.
7. Louis, E., J. Belaiche, C. van Kemseke, D. Franchimont, D. de Groote, V. Gueenen, and J. Y. Mary. 1997. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur. J. Gastroenterol. Hepatol. 9:939.
8. Kusugami, K., A. Fukatsu, M. Tanimoto, M. Shinoda, J. Haruta, A. Kuroiwa, K. Ina, K. Kanayama, T. Ando, and T. Matsuura. 1995. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Dig. Dis. Sci. 40:949.
9. Weinstein, D. L., B. L. O'Neill, and E. S. Metcalf. 1997. Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6. Infect. Immun. 65:395.
10. Sitaraman, S. V., D. Merlin, L. Wang, M. Wong, A. T. Gewirtz, M. Si-Tahar, and J. L. Madara. 2001. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J. Clin. Invest. 107:861.
11. Parikh, A. A., A. L. Salzman, J. E. Fischer, C. Szabo, and P. O. Hasselgren. 1997. Interleukin-1β and interferon-γ regulate interleukin-6 production in cultured human intestinal epithelial cells. Shock 8:249.
12. Heinrich, P. C., I. Behrmann, G. Muller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway. Biochem. J. 334:297.
13. Hosokawa, T., K. Kusugami, K. Ina, T. Ando, M. Shinoda, A. Imada, M. Ohsuga, T. Sakai, T. Matsuura, K. Ito, and K. Kaneshiro. 1999. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J. Gastroenterol. Hepatol. 14:987.
14. Shirota, K., L. LeDuy, S. Y. Yuan, and S. Jothy. 1990. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch. B Cell Pathol. Include. Mol. Pathol. 58:303.
15. Panja, A., S. Goldberg, L. Eckmann, P. Krishen, and L. Mayer. 1998. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161:3675.
16. Keller, E. T., J. Wanagat, and W. B. 1996. Ershler. Molecular and cellular biology of interleukin-6 and its receptor. Front. Biosci. 1:d340.
17. Krebs, D. L., and D. J. Hilton. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378.
18. Greenhalgh, C. J., M. E. Miller, D. J. Hilton, and P. K. Lund. 2002. Suppressors of cytokine signaling: relevance to gastrointestinal function and disease. Gastroenterology 123:2064.
19. Shouda, T., T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, K. Miyoshi, S. Komiya, K. Kosai, Y. Hanakawa, K. Hashimoto, et al. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108:1781.
20. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725.
21. Jobin, C., C. Hellerbrand, L. L. Licato, D. A. Brenner, and R. B. Sartor. 1998. Mediation by NF-ΚB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 42:779.
22. Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135.
23. Parkos, C. A., S. P. Colgan, M. S. Diamond, A. Nusrat, T. W. Liang, T. A. Springer, and J. L. Madara, 1996. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD1 1b/CDI 8-mediated interactions with neutrophils. Mol. Med. 2:489.
24. Staunton, D. E., S. D. Marlin, C. Stratowa, M. L. Dustin, and T. A. Springer. 1988. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925.
25. Huang, G. T., L. Eckmann, T. C. Savidge, and M. F. Kagnoff. 1996. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J. Clin. Invest. 98:572.
26. Colgan, S. P., C. A. Parkos, C. Delp, M. A. Amaout, and J. L. Madara. 1993. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-γ in a highly polarized fashion. J. Cell Biol. 120:785.
27. Bums, R. C., J. Rivera-Nieves, C. A. Moskaluk, S. Matsumoto, F. Cominelli, and K. Ley. 2001. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 121:1428.
28. Yacyshyn, B. R., W. Y. Chey, J. Goff, B. Salzberg, R. Baerg, A. L. Buchman, J. Tami, R. Yu, E. Gibiansky, and W. R. Shanahan. 2002. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut 51:30.
29. Kvale, D., P. Krajci, and P. Brandtzaeg. 1992. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand. J. Immmunol. 35:669.
30. Caldenhoven, E., T. van Dijk, J. A. Raaijmakers, J. W. Lammers. L. Koenderman, and R. P. De Groot. 1995. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J. Biol. Chem. 270:25778.
31. Wooten, D. K., X. Xie, D. Barios, R. A. Busche, G. D. Longmore, and S. S. Watowich. 2000. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J. Biol. Chem. 275:26566.
32. Ledebur, H. C., and T. P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 ene by inflammatory cytokines in human endothelial cells: essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270:933.
33. Cantwell, C. A., E. Stemeck, and P. F. Johnson. 1998. Interleukin-6-specific activation of the C/EBPδ gene in hepatocytes is mediated by Stat3 and Spl. Mol. Cell. Biol. 18:2108.
34. 2+-mediated activation of the NF-κB pathway. J. Clin. Invest. 105:79.
35. Mooseker, M. S. 1985. Organization, chemistry, and assembly of the cytoskeletal apparatus of the intestinal brush border. Annu. Rev. Cell Biol. 1:209.
36. 1 integrin distribution in polarized columnar epithelia. J. Biol. Chem. 276:39282.
37. Merlin, D., M. Si-Tahar, S. V. Sitaraman, K. Eastbum, I. Williams, X. Liu, M. A. Hediger, and J. L. Madara. 2001. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class I molecules. Gastroenterology 120:1666.
38. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917.
39. Voraberger, G., R. Schafer, and C. Stratowa. 1991. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: induction by cytokines and phorbol ester. J. Immunol. 147:2777.
40. Paxton, L. L., L. J. Li, V. Secor, J. L. Duff, S. M. Naik, N. Shibagaki, and S. W. Caughman. 1997. Flanking sequences for the human intercellular adhesion molecule-1 NF-κB response element are necessary for tumor necrosis factor α-induced gene expression. J. Biol. Chem. 272:15928.
41. Seitz, C. S., Q. Lin, H. Deng, and P. A. Khavari. 1998. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. USA 95:2307.
42. Thaloor, D., K. J. Miller, J. Gephart, P. O. Mitchell, and G. K.1999. Pavlath: systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Aro. J. Physiol. 277:C320.
43. Fehlbaum, P., M. Rao, M. Zasloff, and G. M. Anderson. 2000. An essential amino acid induces epithelial β-defensin expression. Proc. Natl. Acad. Sci. USA 97:12723.
44. Sitaraman, S. V., L. Wang, M. Wong, M. Bruewer, M. Hobert, C. H. Yun, D. Merlin, and J. L. Madara. 2002. The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and Ezrin upon agonist stimulation. J. Biol. Chem. 277:33188.
45. Molmenti, E. P., T. Ziambaras, and D. H. Perlmutter. 1993. Evidence for an acute phase response in human intestinal epithelial cells. J. Biol. Chem. 268:14116.
46. Chen, R. H., M. C. Chang, Y. H. Su, Y. T. Tsai, and M. L. Kuo. 1999. Interleukin-6 inhibits transforming growth factor-β-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274:23013.
47. Yang, C. H., A. Murti, S. R. Pfeffer, J. G. Kim, D. B. Donner, and L. M. Pfeffer. 2001. Interferon α/β promotes cell survival by activating nuclear factor κB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 276:13756.
48. Kuo, M. L., S. E. Chuang, M. T. Lin, and S. Y. Yang. 2001. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20:677.